These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23047570)

  • 41. Factors predicting trastuzumab-related cardiotoxicity in a real-world population of women with HER2+ breast cancer.
    Naumann D; Rusius V; Margiotta C; Nevill A; Carmichael A; Rea D; Sintler M
    Anticancer Res; 2013 Apr; 33(4):1717-20. PubMed ID: 23564821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison of stress echocardiography and radionuclide ventriculography in the diagnosis of cardiomyopathy in patients receiving chemotherapy for malignant diseases].
    Leischik R; Eising EG; Katz M; Glattki G; Bruch C; Seeber S; Bockisch A; Erbel R
    Dtsch Med Wochenschr; 1997 Dec; 122(49):1509-15. PubMed ID: 9453916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trastuzumab-induced cardiotoxicity: heart failure at the crossroads.
    Sengupta PP; Northfelt DW; Gentile F; Zamorano JL; Khandheria BK
    Mayo Clin Proc; 2008 Feb; 83(2):197-203. PubMed ID: 18241629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.
    Bird BR; Swain SM
    Clin Cancer Res; 2008 Jan; 14(1):14-24. PubMed ID: 18172247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The concurrent use of aromatase inhibitors and radiotherapy induces echocardiographic changes in patients with breast cancer.
    Skyttä T; Tuohinen S; Virtanen V; Raatikainen P; Kellokumpu-Lehtinen PL
    Anticancer Res; 2015 Mar; 35(3):1559-66. PubMed ID: 25750311
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective comparison of cardiac magnetic resonance imaging and radionuclide ventriculography in the assessment of cardiac function in patients treated with anthracycline-based chemotherapy.
    Sipola P; Vanninen E; Jantunen E; Nousiainen T; Kiviniemi M; Hartikainen J; Kuittinen T
    Nucl Med Commun; 2012 Jan; 33(1):51-9. PubMed ID: 22044862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exercise radionuclide ventriculography for predicting post-operative left ventricular function in chronic aortic regurgitation.
    Tamás E; Broqvist M; Olsson E; Franzén S; Nylander E
    JACC Cardiovasc Imaging; 2009 Jan; 2(1):48-55. PubMed ID: 19356532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dobutamine stress echocardiography identifies anthracycline cardiotoxicity.
    Cottin Y; L'huillier I; Casasnovas O; Geoffroy C; Caillot D; Zeller M; Solary E; Guy H; Wolf JE
    Eur J Echocardiogr; 2000 Sep; 1(3):180-3. PubMed ID: 11916591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer.
    Appel JM; Zerahn B; Møller S; Christensen HM; Søgaard P; Ejlertsen B; Fogh-Andersen N; Jensen BV; Nielsen DL
    Acta Oncol; 2012 Nov; 51(8):1054-61. PubMed ID: 22909389
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Normal tissue tolerance to external beam radiation therapy: cardiac structures].
    Doyen J; Giraud P; Belkacemi Y
    Cancer Radiother; 2010 Jul; 14(4-5):319-26. PubMed ID: 20547085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Correlation between left ventricular ejection fraction assessed by gated SPECT and radionuclide ventriculography in patients with ischemic cardiomyopathy].
    Alexánderson E; Gómez-Martín D; Fermon S; Meave A
    Arch Cardiol Mex; 2004; 74(1):25-30. PubMed ID: 15125263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective cardiac MRI for the analysis of biventricular function in children undergoing cancer treatments.
    de Ville de Goyet M; Brichard B; Robert A; Renard L; Veyckemans F; Vanhoutte L; Moniotte S
    Pediatr Blood Cancer; 2015 May; 62(5):867-74. PubMed ID: 25597617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
    Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
    Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Monitoring left ventricular function in adults receiving anthracycline-containing chemotherapy.
    Belham M; Kruger A; Mepham S; Faganello G; Pritchard C
    Eur J Heart Fail; 2007 Apr; 9(4):409-14. PubMed ID: 17067854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer.
    Abu-Khalaf MM; Juneja V; Chung GG; DiGiovanna MP; Sipples R; McGurk M; Zelterman D; Haffty B; Reiss M; Wackers FJ; Lee FA; Burtness BA
    Breast Cancer Res Treat; 2007 Sep; 104(3):341-9. PubMed ID: 17051423
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.
    Thavendiranathan P; Grant AD; Negishi T; Plana JC; Popović ZB; Marwick TH
    J Am Coll Cardiol; 2013 Jan; 61(1):77-84. PubMed ID: 23199515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiotoxicity of cancer chemotherapy in clinical practice.
    Jain D; Aronow W
    Hosp Pract (1995); 2019 Feb; 47(1):6-15. PubMed ID: 30270693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prognostic role of p53 gene polymorphism in risk assessment of anthracycline-induced cardiotoxicity].
    Shilov SN; Teplyakov AT; Popova AA; Berezikova EN; Neupokoeva MN; Grakova EV; Valeeva AM; Tuleutaev SM
    Kardiologiia; 2019 Aug; 59(7S):15-22. PubMed ID: 31441737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.